Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
January 27, 2022 03:02 pm

Moderna Starts Trial of an Omicron-specific COVID-19 Vaccine

Moderna gave its omicron-specific COVID-19 vaccine to the first participant in a clinical trial, the company announced Wednesday. The report comes a few days after Pfizer / BioNTech launched a trial of its shot targeting the fast-spreading variant. From a report: The announcement coincides with the release of data showing that the two-dose series of Moderna's original vaccine struggled to block the omicron variant of the virus, which has mutations that help it dodge those antibodies. A booster shot restored much of its ability to neutralize the virus -- and while that protection weakened over time, it still stuck around for at least six months. Still, Moderna CEO Stephane Bancel said in a statement that the omicron variant is enough of a threat that the company plans to move forward with the variant booster.

Read more of this story at Slashdot.


Original Link: https://science.slashdot.org/story/22/01/27/154234/moderna-starts-trial-of-an-omicron-specific-covid-19-vaccine?utm_source=rss1.0mainlinkanon&utm_medi

Share this article:    Share on Facebook
View Full Article

Slashdot

Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..

More About this Source Visit Slashdot